Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1985 Mar;12(1):9–21.

Heart Disease in Systemic Lupus Erythematosus: Diagnosis and Management

Azam Ansari 1,2, Paul H Larson 1,2
PMCID: PMC341784  PMID: 15227037

Abstract

Most patients suffering from systemic lupus erythematosus develop secondary heart disease at some time during the course of the primary illness. The most common forms of this type of heart disease are acute fibrinous pericarditis and hypertension. By means of echocardiography, an increased incidence of pericardial effusion has been demonstrated. Although commonly noted at autopsy, myocarditis is often clinically silent. However, endomyocardial biopsy may confirm its presence during life. Libman-Sacks endocarditis, although encountered in 40 to 50% of hearts at autopsy, is rarely diagnosed during life. When significant valve dysfunction such as aortic insufficiency or mitral regurgitation develops during the course of systemic lupus erythematosus, then Libman-Sacks endocarditis should be strongly suspected.

Cardiac arrhythmias, first degree AV block, and acquired complete heart block may develop either de novo or in association with lupus pericarditis, myocarditis, vasculitis, etc. Complete congenital heart block has been reported in newborns of mothers with systemic lupus erythematosus, particularly those who have an antibody to a soluble tissue ribonucleoprotein antigen called RO(SS-A).

Coronary arteritis and premature coronary atherosclerosis manifesting in either angina pectoris or myocardial infarction in young adults, particularly women suffering from systemic lupus erythematosus, have received attention recently. The development of hypertension and hyperlipidemia while such patients are receiving prolonged corticosteroid therapy has been incriminated as the significant risk factor in premature coronary atherosclerosis. Longstanding hypertension and congestive heart failure have unfavorable prognoses.

This report is based on a cumulative review of 50 patients with acute and chronic systemic lupus erythematosus seen at our institution and in private practice during the last 10 years.

Full text

PDF
10

Images in this article

10Image
on p.10
11Image
on p.11
12Image
on p.12
13Image
on p.13
14Image
on p.14
14Image
on p.14
15Image
on p.15
16Image
on p.16
17Image
on p.17
17Image
on p.17
18Image
on p.18
19Image
on p.19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRIGDEN W., BYWATERS E. G., LESSOF M. H., ROSS I. P. The heart in systemic lupus erythematosus. Br Heart J. 1960 Jan;22:1–16. doi: 10.1136/hrt.22.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borenstein D. G., Fye W. B., Arnett F. C., Stevens M. B. The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med. 1978 Nov;89(5 Pt 1):619–624. doi: 10.7326/0003-4819-89-5-619. [DOI] [PubMed] [Google Scholar]
  3. Bulkley B. H., Roberts W. C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med. 1975 Feb;58(2):243–264. doi: 10.1016/0002-9343(75)90575-6. [DOI] [PubMed] [Google Scholar]
  4. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  5. Gross L. The cardiac lesions in Libman-Sacks disease: With a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol. 1940 Jul;16(4):375–408.11. [PMC free article] [PubMed] [Google Scholar]
  6. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  7. Haider Y. S., Roberts W. C. Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med. 1981 Apr;70(4):775–781. doi: 10.1016/0002-9343(81)90532-5. [DOI] [PubMed] [Google Scholar]
  8. Hess E. V., Spencer-Green G. Congenital heart block and connective tissue disease. Ann Intern Med. 1979 Oct;91(4):645–646. doi: 10.7326/0003-4819-91-4-645. [DOI] [PubMed] [Google Scholar]
  9. Homcy C. J., Liberthson R. R., Fallon J. T., Gross S., Miller L. M. Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol. 1982 Feb 1;49(2):478–484. doi: 10.1016/0002-9149(82)90528-8. [DOI] [PubMed] [Google Scholar]
  10. JAMES T. N., RUPE C. E., MONTO R. W. PATHOLOGY OF THE CARDIAC CONDUCTION SYSTEM IN SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Intern Med. 1965 Sep;63:402–410. doi: 10.7326/0003-4819-63-3-402. [DOI] [PubMed] [Google Scholar]
  11. SCHOENFELD M. R., MESSELOFF C. R. Cardiac tamponade in systemic lupus erythematosus. Circulation. 1963 Jan;27:98–99. doi: 10.1161/01.cir.27.1.98. [DOI] [PubMed] [Google Scholar]
  12. Scott J. S., Maddison P. J., Taylor P. V., Esscher E., Scott O., Skinner R. P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983 Jul 28;309(4):209–212. doi: 10.1056/NEJM198307283090403. [DOI] [PubMed] [Google Scholar]
  13. YURCHAK P. M., LEVINE S. A., GORLIN R. CONSTRICTIVE PERICARDITIS COMPLICATING DISSEMINATED LUPUS ERYTHEMATOSUS. Circulation. 1965 Jan;31:113–118. doi: 10.1161/01.cir.31.1.113. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES